跳至主要内容
临床试验/CTRI/2017/07/008974
CTRI/2017/07/008974尚未招募未知

Feasibility Study of an Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease.

Applaud Medical Inc0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Individuals presenting with one urinary stoneâ??
  • apparent on a computed tomography (CT) scan within
  • the last 14 days.
  • 2. Males and females aged 18 or older will be
  • included. No preference will be given to gender,
  • although men have a higher prevalence of stone
  • disease than women.
  • 3. Capable of giving informed consent, and willing to
  • have the informed consent process videotaped.
  • 4. Stone size, as estimated by pre-operative CT, with
  • all dimensions 15 mm or less.

排除标准

  • 1. Individuals under 18 years of age.
  • 2. Individuals with radiolucent stones.
  • 3. Individuals with stones in the lower pole of
  • 4. Individuals not following up in the treating
  • 5. Individuals with history of cystinuria.
  • 6. Individuals with urine pH below 5.5.
  • 7. Individuals with untreated urinary tract
  • 8. Individuals who are not willing to use adequate
  • method of contraception during the study period.
  • 9. Women who are pregnant, lactating or planning
  • pregnancy during the study period. Individuals
  • with a coagulation abnormality or taking
  • prescription anticoagulants. Aspirin usage will be
  • discontinued at least 7 days prior to enrollment
  • at the discretion of the attending physician.
  • 10. Individuals with mobility issues who are unable
  • to comfortably lie still for up to 30 minutes or
  • roll from their back to their side.
  • 11. Individuals belonging to a vulnerable group
  • (pregnant, mentally disabled, physically
  • disabled, prisoner, etc.).
  • 12. Individuals with a BMI greater than 35.
  • 13. Individuals with ASA score of 3 or greater
  • general anesthesia risk level
  • 14. Known sensitivity to possible medications used
  • before, during, or after the ELS procedure,
  • including but not limited to the following:
  • sedative agents, general anesthetics, topical
  • anesthetics, and opioid analgesics.

研究者

发起方
Applaud Medical Inc

相似试验